acute myocardial infarction

Proximal anterior descending artery angioplasty: what are its long-term outcomes?

Courtesy of Dr. Javier Castro. Certain coronary lesions have been historically discouraged for endovascular treatment. Among these can be found left main coronary artery lesions, multivessel disease, and proximal anterior descending artery lesions. As a matter of fact, the latter is actually considered separately as a criterion for choosing the revascularization method. Endovascular treatment of<a href="https://solaci.org/en/2017/04/20/proximal-anterior-descending-artery-angioplasty-what-are-its-long-term-outcomes/" title="Read more" >...</a>

ffr para guiar revascularizacion en SCA

FFR-Guided ACS Revascularization Apparently Superior to Culprit Vessel Treatment

Using fractional flow reserve (FFR) to guide revascularization of all functionally significant lesions in the setting of acute coronary syndrome appears to improve outcomes over treating only the culprit artery, according to the Compare-Acute trial. &nbsp; This study, conducted at 24&nbsp;centers in Europe and Asia, enrolled 885&nbsp;patients who were stable following successful primary angioplasty and<a href="https://solaci.org/en/2017/04/11/ffr-guided-acs-revascularization-apparently-superior-to-culprit-vessel-treatment/" title="Read more" >...</a>

Embarazo y riesgo de disección arterial coronaria espontánea

Pregnancy and Risk of Spontaneous Coronary Artery Dissection: How to Proceed

Courtesy of Dr. Pablo Baglioni. Between the years 2000 and 2015, the authors of this article searched for reports on spontaneous coronary artery dissection (SCAD) in pregnant or immediate post-partum women aiming at defining the clinical characteristics of this pathology and offering management recommendations. &nbsp; Information on 120 women was analyzed; 116 were between 22<a href="https://solaci.org/en/2017/04/03/pregnancy-and-risk-of-spontaneous-coronary-artery-dissection-how-to-proceed/" title="Read more" >...</a>

synergy vs XIENCE

SYNERGY vs. XIENCE in Complex Real-World Patients

Courtesy of Dr. Guillermo Migliaro. Technological advancements in drug-eluting stents (DES) have shown significant improvement as regards the safety and efficacy of these devices. DES are considered to be the golden standard for the treatment of percutaneous coronary interventions. &nbsp; DES with permanent or durable polymers (DP) have been associated with local inflammatory reactions and<a href="https://solaci.org/en/2017/04/01/synergy-vs-xience-in-complex-real-world-patients/" title="Read more" >...</a>

anuloplastia mitral percutánea

Percutaneous Mitral Annuloplasty: First Results in Humans

&nbsp;Courtesy of Dr.&nbsp;Agustín&nbsp;Vecchia.&nbsp; In the last few years, new percutaneous treatment options for mitral regurgitation have emerged. Transcatheter mitral annuloplasty with various devices is a relatively simple procedure that could compress the origin of circumflex artery branches due to the different orientation of mitral corners and the coronary sinus. &nbsp; The following work by Park<a href="https://solaci.org/en/2017/03/27/percutaneous-mitral-annuloplasty-first-results-in-humans/" title="Read more" >...</a>

desensibilizacion a la aspirina

Aspirin Desensitization in Patients with Coronary Artery Disease

There are limited data on aspirin desensitization in patients with coronary artery disease (CAD). The aim of this study was to test the safety and efficacy of a rapid desensitization protocol inpatients with a history of aspirin sensitivity about to receive PCI. &nbsp; This was a prospective multicenter observational study, carried out in seven Italian<a href="https://solaci.org/en/2017/03/06/aspirin-desensitization-in-patients-with-coronary-artery-disease/" title="Read more" >...</a>

tromboaspiracion angioplastia primaria

Thrombus Aspiration during Primary PCI Does Not Improve Clinical Outcomes

Thrombus aspiration during primary PCI in ST elevation MI has been extensively used; however, recent studies have questioned its efficacy and safety. &nbsp; This meta-analysis looked into individual patient data to determine the benefit and safety of thrombus aspiration during primary PCI. &nbsp; It included all randomized and controlled studies assessing manual thrombectomy vs. conventional<a href="https://solaci.org/en/2017/01/09/thrombus-aspiration-during-primary-pci-does-not-improve-clinical-outcomes/" title="Read more" >...</a>

ticagrelor vs clopidogrel en enfermedad vascular periferica

Ticagrelor Versus Clopidogrel in Symptomatic Peripheral Vascular Disease

Peripheral vascular disease is considered as a manifestation of systemic atherosclerosis associated with adverse events, both cardiovascular and related to the lower limbs. &nbsp; Previous studies showed that clopidogrel monotherapy is associated with lower risk of events when compared to low doses of aspirin. Such is the rationale behind this article comparing clopidogrel and ticagrelor<a href="https://solaci.org/en/2017/01/04/ticagrelor-versus-clopidogrel-in-symptomatic-peripheral-vascular-disease/" title="Read more" >...</a>

pacientes anticoagulados por fibrilación auricular que reciben angioplastia tratamiento

Anticoagulated Patients with Atrial Fibrillation Undergoing Angioplasty: How to Treat Them

In patients with atrial fibrillation undergoing coronary angioplasty with stents, standard anticoagulation with vitamin K antagonists plus dual antiplatelet therapy with a P2Y12 inhibitor and aspirin reduces the risk of stent thrombosis and stroke, but increases the risk of bleeding. &nbsp; The effectiveness and safety of anticoagulation with rivaroxaban plus one or two antiplatelet agents<a href="https://solaci.org/en/2016/12/26/anticoagulated-patients-with-atrial-fibrillation-undergoing-angioplasty-how-to-treat-them/" title="Read more" >...</a>

FUTURE: aumento de la mortalidad en la rama FFR

FUTURE: Mortality Increase in the FFR Arm, Real or Casual?

The FUTURE study, testing the&nbsp;utility of functional revascularization by measuring the fractional flow reserve (FFR), was halted early by its safety committee due to an increased mortality rate at 1&nbsp;year among patients guided by FFR. &nbsp; In this unexpected unprecedented outcome, 17&nbsp;patients in the FFR-guided group died at a year of follow-up, compared with 7&nbsp;patients<a href="https://solaci.org/en/2016/12/01/future-mortality-increase-in-the-ffr-arm-real-or-casual/" title="Read more" >...</a>

Top